| Robert Neal Aguillard, MD | |
|
5050 Poplar Ave, Suite 800, Memphis, TN 38157-0101 | |
| (901) 276-2662 | |
| (901) 274-1871 |
| Full Name | Robert Neal Aguillard |
|---|---|
| Gender | Male |
| Speciality | Critical Care (intensivists) |
| Experience | 40 Years |
| Location | 5050 Poplar Ave, Memphis, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659362960 | NPI | - | NPPES |
| 3013886 | Medicaid | TN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-south Pulmonary Specialists Pc | 5092700518 | 38 |
| Mid-south Pulmonary Specialists Pc | 5092700518 | 38 |
News Archive
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today.
Alere Inc., a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).
A normal intake of vitamin D can reduce the risk of death substantially in people with cardiovascular disease, a Norwegian study shows.
› Verified 5 days ago
| Entity Name | Mid-south Pulmonary Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073592275 PECOS PAC ID: 5092700518 Enrollment ID: O20040415000557 |
News Archive
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today.
Alere Inc., a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).
A normal intake of vitamin D can reduce the risk of death substantially in people with cardiovascular disease, a Norwegian study shows.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Neal Aguillard, MD 5050 Poplar Ave, Suite 800, Memphis, TN 38157-0101 Ph: (901) 276-2662 | Robert Neal Aguillard, MD 5050 Poplar Ave, Suite 800, Memphis, TN 38157-0101 Ph: (901) 276-2662 |
News Archive
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists for the treatment of cancer, respiratory and autoimmune diseases, today announced the presentation of results from a Phase 1 clinical trial of VTX-2337, a selective TLR8 agonist in patients with advanced solid tumors. Data were presented at the American Society of Clinical Oncology Annual Meeting in Chicago, IL.
Wearables is very much an emerging trend and healthcare is leading this effort. Consumer technology, such as the FitBit, Jawbone, and others, are going to merge with medical devices that are already being used in hospitals today.
Alere Inc., a global leader in rapid diagnostics, today has declared a cash dividend of $3.00 per share on its Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).
A normal intake of vitamin D can reduce the risk of death substantially in people with cardiovascular disease, a Norwegian study shows.
› Verified 5 days ago
Khawaja Muhammad Muddassir, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave, Suite 370, Memphis, TN 38104 Phone: 901-758-7888 Fax: 901-387-5153 | |
Dr. Jordan Redfield, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 920 Madison Ave Ste 447, Memphis, TN 38103 Phone: 901-448-5814 | |
Allison Montague, Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1955 S 3rd St, Memphis, TN 38109 Phone: 901-515-5800 | |
Dr. Marcia Bradford, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 360 E Eh Crump Blvd, Memphis, TN 38126 Phone: 901-261-2000 Fax: 901-946-9262 | |
Dr. Aleksandar Jankov, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd, Suite 301, Memphis, TN 38120 Phone: 901-747-9081 Fax: 901-747-9087 | |
Manoj K Jain, MD, MPH Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 6029 Walnut Grove Rd Ste 209, Memphis, TN 38120 Phone: 901-681-0778 Fax: 901-821-9987 | |
Dr. Karl Weber, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 880 Madison Ave, Memphis, TN 38103 Phone: 901-545-6969 Fax: 901-545-4739 |